Although the mechanisms underpinning this relationship are currently unclear, the Authors concluded that MGMT hypermethylation might be associated with a lower risk of recurrence in CRC patients receiving adjuvant chemotherapy. This evidence concerns the gene MGMT and colorectal carcinoma.